Lazari Capital Management, Inc. Geron Corp Transaction History
Lazari Capital Management, Inc.
- $184 Billion
- Q1 2024
A detailed history of Lazari Capital Management, Inc. transactions in Geron Corp stock. As of the latest transaction made, Lazari Capital Management, Inc. holds 93,424 shares of GERN stock, worth $429,750. This represents 0.17% of its overall portfolio holdings.
Number of Shares
93,424
Previous 114,424
18.35%
Holding current value
$429,750
Previous $241 Million
27.69%
% of portfolio
0.17%
Previous 0.14%
Shares
4 transactions
Others Institutions Holding GERN
# of Institutions
258Shares Held
374MCall Options Held
1.48MPut Options Held
1.18M-
Black Rock Inc. New York, NY41.4MShares$191 Million0.0% of portfolio
-
State Street Corp Boston, MA31.6MShares$145 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT30.5MShares$140 Million3.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.9MShares$137 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$125 Million12.02% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.74B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...